share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

Recursion Pharmaceuticals | 4：持股变动声明-董事 Li Dean Y
美股sec公告 ·  06/05 18:17
Moomoo AI 已提取核心信息
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on June 3, 2024. A total of 13,097 shares of Class A Common Stock were acquired at no cost, as part of the grant. Following this transaction, Li directly holds 72,186 shares of the company's stock. Additionally, Li has indirect beneficial ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on June 3, 2024. A total of 13,097 shares of Class A Common Stock were acquired at no cost, as part of the grant. Following this transaction, Li directly holds 72,186 shares of the company's stock. Additionally, Li has indirect beneficial ownership of 3,112,844 shares through various trusts, including the Dean Li and Ruth Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
2024年6月3日，与Recursion Pharmaceuticals，Inc. [RXRX]有关的Dean Y. Li完成了一笔股票授予交易。作为授予的一部分，共获得了13,097股A类普通股，无需支付费用。此次交易后，Li直接持有公司股票72,186股。此外，Li通过多个信托机构（包括Dean Li与Ruth Li可撤销信托基金，Dean Y. Li GRAT和Dean Y. Li 2021家庭信托等）间接拥有3,112,844股受益所有权。
2024年6月3日，与Recursion Pharmaceuticals，Inc. [RXRX]有关的Dean Y. Li完成了一笔股票授予交易。作为授予的一部分，共获得了13,097股A类普通股，无需支付费用。此次交易后，Li直接持有公司股票72,186股。此外，Li通过多个信托机构（包括Dean Li与Ruth Li可撤销信托基金，Dean Y. Li GRAT和Dean Y. Li 2021家庭信托等）间接拥有3,112,844股受益所有权。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息